Switch theme
Sign up to access all valuation multiples
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
2016
44
LTM Revenue $4.0M
LTM EBITDA -$84.2M
-$32.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Shattuck Labs has a last 12-month revenue of $4.0M and a last 12-month EBITDA of -$84.2M.
In the most recent fiscal year, Shattuck Labs achieved revenue of $5.7M and an EBITDA of -$76.7M.
Shattuck Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Shattuck Labs valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.7M | $5.7M | XXX | XXX | XXX |
| Gross Profit | n/a | n/a | XXX | XXX | XXX |
| Gross Margin | NaN% | NaN% | XXX | XXX | XXX |
| EBITDA | -$87.9M | -$76.7M | XXX | XXX | XXX |
| EBITDA Margin | -5306% | -1341% | XXX | XXX | XXX |
| Net Profit | -$102M | -$87.3M | XXX | XXX | XXX |
| Net Margin | -6152% | -1526% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 18, 2025, Shattuck Labs's stock price is $1.
Shattuck Labs has current market cap of $37.0M, and EV of -$32.5M.
See Shattuck Labs trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| -$32.5M | $37.0M | XXX | XXX | XXX | XXX | $-1.35 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 18, 2025, Shattuck Labs has market cap of $37.0M and EV of -$32.5M.
Shattuck Labs's trades at -8.1x LTM EV/Revenue multiple, and 0.4x LTM EBITDA.
Analysts estimate Shattuck Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Shattuck Labs and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | -$32.5M | XXX | XXX | XXX |
| EV/Revenue | -5.7x | XXX | XXX | XXX |
| EV/EBITDA | 0.4x | XXX | XXX | XXX |
| P/E | -0.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 0.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpShattuck Labs's NTM/LTM revenue growth is -100%
Shattuck Labs's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $2.0M for the same period.
Over next 12 months, Shattuck Labs's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Shattuck Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Shattuck Labs and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 245% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -1341% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -13% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $2.0M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 333% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1175% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 1508% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shattuck Labs acquired XXX companies to date.
Last acquisition by Shattuck Labs was XXXXXXXX, XXXXX XXXXX XXXXXX . Shattuck Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Shattuck Labs founded? | Shattuck Labs was founded in 2016. |
| Where is Shattuck Labs headquartered? | Shattuck Labs is headquartered in United States of America. |
| How many employees does Shattuck Labs have? | As of today, Shattuck Labs has 44 employees. |
| Who is the CEO of Shattuck Labs? | Shattuck Labs's CEO is Dr. Taylor H. Schreiber, M.D.,PhD. |
| Is Shattuck Labs publicy listed? | Yes, Shattuck Labs is a public company listed on NAS. |
| What is the stock symbol of Shattuck Labs? | Shattuck Labs trades under STTK ticker. |
| When did Shattuck Labs go public? | Shattuck Labs went public in 2020. |
| Who are competitors of Shattuck Labs? | Similar companies to Shattuck Labs include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Shattuck Labs? | Shattuck Labs's current market cap is $37.0M |
| What is the current revenue of Shattuck Labs? | Shattuck Labs's last 12-month revenue is $4.0M. |
| What is the current EBITDA of Shattuck Labs? | Shattuck Labs's last 12-month EBITDA is -$84.2M. |
| What is the current EV/Revenue multiple of Shattuck Labs? | Current revenue multiple of Shattuck Labs is -8.1x. |
| What is the current EV/EBITDA multiple of Shattuck Labs? | Current EBITDA multiple of Shattuck Labs is 0.4x. |
| What is the current revenue growth of Shattuck Labs? | Shattuck Labs revenue growth between 2023 and 2024 was 245%. |
| Is Shattuck Labs profitable? | Yes, Shattuck Labs is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
